Events1st International Electronic Conference on Medicinal Chemistry
Published
This submission belongs to the session A. ECMC-1 of the event 1st International Electronic Conference on Medicinal Chemistry
Published date
02 Nov, 2015
Citation
Amalia Di Petrillo, Antonella Fais, Benedetta Era, Eugenio Uriarte, Fernanda Borges, Francesca Pintus, Lourdes Santana, Maria João Matos, Rosaria Medda, Adriana Murgia, Study of a Series of 8-Substitued 7-hydroxy-4-methylcoumarins as AChE and BuChE Inhibitors, in Proceedings of 1st International Electronic Conference on Medicinal Chemistry, 2 November–27 November 2015, MDPI: Basel, Switzerland, doi: 10.3390/ecmc-1-A027
Share
Email
Facebook
Twitter
LinkedIn

Study of a Series of 8-Substitued 7-hydroxy-4-methylcoumarins as AChE and BuChE Inhibitors

image
image
Rosaria Medda 3
Adriana Murgia 3
Amalia Di Petrillo 3
1. Departamento de Química Orgánica, Facultad de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain
2. CIQUP/Department of Chemistry and Biochemistry, Faculty of Sciences, University of Porto, 4169-007 Porto, Portugal
3. Department of Life Science and Environment, University of Cagliari, 09042 Monserrato, Cagliari, Italy
Abstract
In the current work we studied the interest of a series of 8-substitued 7-hydroxy-4-methylcoumarins as acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) inhibitors. For the best compounds of the series, the IC50 value was determined. This work was based on previous results and is a preliminary screening for further design and synthesis of new derivatives as potential compounds that can modulate enzymatic systems involved in the neurodegenerative diseases.
Keywords
8-Substitued 7-hydroxy-4-methylcoumarins • Acylation reaction • Acetylcholinesterase inhibitors • Butyrylcholinesterase inhibitors • Alzheimer’s disease
Poster
Matos et al.pdf
Ionic Liquids Coupled to Microwave Irradiation: an Efficient and Selective Process for Secondary Lichens Metabolites Extraction
Limiting the Number of Potential Binding Modes by Introducing Symmetry into Ligands: Structure-Based Design of Inhibitors for Trypsin-Like Serine Proteases